RE: Who trial wasnt a trial at all for traumakine16 Oct 2020 13:51
They took our drug, Hardly used it and when they did they used it wrong.. in effect we were not even in the trial.
Key points from the RNS:
"Traumakine...it had seldom been used.
"The WHO has not been able to verify how many patients received Traumakine ....
"About half of the patients receiving IFN beta-1a also received concomitant corticosteroids"
"IFN beta-1a is likely to be ineffective when given subcutaneously"
"Compared to subcutaneous IFN beta-1a, the same amount of intravenous IFN beta-1a achieves over 150x higher peak concentration in the lung vasculature without higher systemic exposure3"